{{Rsnum
|rsid=6941421
|Chromosome=6
|position=15088920
|Orientation=plus
|GMAF=0.3444
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 18.6 | 38.1 | 43.4
| HCB | 10.2 | 46.7 | 43.1
| JPT | 6.2 | 49.6 | 44.2
| YRI | 5.4 | 40.8 | 53.7
| ASW | 8.8 | 33.3 | 57.9
| CHB | 10.2 | 46.7 | 43.1
| CHD | 13.9 | 50.0 | 36.1
| GIH | 14.9 | 55.4 | 29.7
| LWK | 7.3 | 41.3 | 51.4
| MEX | 6.9 | 43.1 | 50.0
| MKK | 5.1 | 46.8 | 48.1
| TSI | 13.7 | 59.8 | 26.5
| HapMapRevision=28
}}{{PMID Auto GWAS
|PMID=19010793
|Trait=Multiple sclerosis (severity)
|Title=Genome-wide association analysis of susceptibility and clinical phenotype in multiple sclerosis
|RiskAllele=
|Pval=0.000006
|OR=NR
|ORtxt=NR
}}

{{PharmGKB
|RSID=rs6941421
|Name_s=
|Gene_s=-
|Feature=
|Evidence=PubMed ID:19010793; Web Resource:http://www.genome.gov/gwastudies/
|Annotation=GWAS results: Genome-wide association analysis of susceptibility and clinical phenotype in multiple sclerosis. (Initial Sample Size: 794 cases, 883 controls; Replication Sample Size: NR); (Region: 6p23; Reported Gene(s): JARID2; Risk Allele: rs6941421-?); (p-value= 0.000006).This variant is associated with Multiple sclerosis (severity).
|Drugs=
|Drug Classes=
|Diseases=Multiple Sclerosis
|Curation Level=Non-Curated
|PharmGKB Accession ID=PA164740726
}}

{{GET Evidence
|impact=pathogenic
|qualified_impact=Insufficiently evaluated pathogenic
|inheritance=unknown
|quality_scores=Array
|dbsnp_id=rs6941421
|overall_frequency_n=31
|overall_frequency_d=128
|overall_frequency=0.242188
|n_genomes=21
|n_genomes_annotated=0
|n_haplomes=23
|n_articles=0
|n_articles_annotated=0
|in_gwas=Y
|in_pharmgkb=Y
|autoscore=2
|webscore=N
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}